ARM 1 Type of group

4 trials

Sponsors

MERCK & CO.INC.,, SCHERING PLOUGH RESEARCH INSTITUTE,, F. HOFFMANN-LA ROCHE LTD.,, GLAXOSMITHKLINE PERU S.A.,

Unknown Phase

Study of Lonafarnib Versus Placebo in Subjects With Either Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Active, not recruitingPER-029-05

SCHERING PLOUGH RESEARCH INSTITUTE,

Start: 2006-03-02Target: 1Updated: 2023-09-04

A Study of Avastin (Bevacizumab) Added to a Chemotherapeutic Regimen in Patients With Metastatic Pancreatic Cancer

Active, not recruitingPER-045-05

F. HOFFMANN-LA ROCHE LTD.,

Start: 2005-10-04Target: 20Updated: 2023-09-04

Study In People With Type 2 Diabetes

Active, not recruitingPER-061-05

GLAXOSMITHKLINE PERU S.A.,

Target: 60Updated: 2023-09-04

Broad Spectrum HPV Vaccine Dose Ranging Study (V502-001)

Active, not recruitingPER-003-06

MERCK & CO.INC.,

Start: 2006-04-10Target: 50Updated: 2023-09-04